Neuropsychological functioning in children with early-treated phenylketonuria: Impact of white matter abnormalities

Peter J. Anderson, Stephen J. Wood, Dorothy E. Francis, Lee Coleman, Linda Warwick, Sue Casanelia, Vicki A. Anderson, Avihu Boneh

Research output: Contribution to journalArticleResearchpeer-review

49 Citations (Scopus)

Abstract

Impact of white matter abnormalities (WMAs) on neuropsychological functioning in children with early-treated phenylketonuria (ETPKU) was examined. Children with ETPKU (20 males, 12 females, mean age 11 years 2 months, SD 3 years 6 months) and controls (20 males, 14 females, mean age 10 years 4 months, SD 3 years 1 month) aged 7 to 18 years were assessed using tests of attention, processing speed, memory and learning, executive function, and academic achievement. Those with ETPKU, exhibiting WMAs extending into subcortical/frontal regions (n=14), displayed significant impairments in a number of domains. Children with ETPKU but no WMAs (n=6), or pathology restricted to the posterior periventricular region (n=12), displayed only mild deficits. Concurrent phenylalanine levels correlated weakly with cognitive parameters, whereas lifetime phenylalanine levels were associated with deficits in several cognitive domain. Impairments in children with extensive WMAs are consistent with compromised neural transmission, which is characterized by dysmyelination. However, children with no detectable, or mild WMAs, also displayed cognitive problems, indicating that neuropsychological functioning in children with ETPKU is determined by a complex interaction of biological and environmental factors.

Original languageEnglish
Pages (from-to)230-238
Number of pages9
JournalDevelopmental Medicine and Child Neurology
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

Cite this